SNORD105: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Target Name: SNORD105

NCBI ID: G692229

SNORD105

Other Name(s): Small nucleolar RNA, C/D box 105 | U105 | small nucleolar RNA, C/D box 105

SNORD105: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Introduction

Small nucleolar RNA (snRNA) is a class of non-coding RNAs that play a critical role in various cellular processes, including DNA replication, gene expression, and RNA splicing. In eukaryotes, snRNA mainly includes three types: snRNA, snRNP and snKNALI. Among them, snRNA is the most common type, accounting for about 80% of all snRNA. SNORD105 is a member of the snRNA family, which encodes an RNA molecule with a length of 105 nucleotides.

The mechanism of action of SNORD105 in vivo and its relationship with diseases have always attracted much attention. This article will discuss the structure, function, potential as a drug target and clinical application of SNORD105.

Structure and function of SNORD105

SNORD105 is a single-stranded RNA whose sequence is conserved in various biological species. Through gene sequencing technology, scientists have discovered the functions of SNORD105 in many organisms, such as participating in gene expression, chromatin structure, DNA binding, etc.

(1) Participate in gene expression

SNORD105 is a member of the RNA-binding protein (RBP) family, members of which typically bind to RNA to regulate gene expression. By binding to RBP, SNORD105 can stably bind to certain RNAs, thereby affecting the stability of these RNAs and thus affecting gene expression.

(2) Participate in chromatin structure

The mechanism by which SNORD105 functions in chromatin is unclear, but studies have shown that the binding of SNORD105 to chromatin may help maintain the structure and stability of chromatin.

(3) Participate in DNA binding

SNORD105 is a DNA-binding protein that can bind to DNA and thus participate in the gene transcription process.

Potential as a drug target

As a new drug target, SNORD105 has high research value. In recent years, with the development of high-throughput screening technology, scientists have discovered a variety of drug molecules targeting SNORD105 and conducted extensive research on their structure, properties and efficacy.

(1) Anti-tumor activity

Studies have found that inhibitors of SNORD105 can significantly inhibit the growth and spread of tumor cells. In addition, inhibitors of SNORD105 can also inhibit the apoptosis of tumor cells, thus providing new ideas for tumor treatment.

(2) Antiviral activity

SNORD105 also has potential application value in antiviral applications. Research shows that SNORD105 can inhibit the replication of HIV-1, providing a new target for anti-HIV viral treatment.

(3) Improve liver function

The liver is an important organ of the human body, and its normal function is crucial to human health. SNORD105 contained in the liver plays an important role in liver function. Studies have found that SNORD105 intervention can improve liver function, thus providing a new method for the treatment of abnormal liver function.

Clinical application

As a new drug target, SNORD105 has broad clinical application prospects. Currently, drug research on SNORD105 has entered the clinical stage, aiming to provide patients with more effective treatments.

in conclusion

SNORD105 is an RNA molecule with a wide range of biological activities and plays an important role in organisms. Through the study of its structure and function, the potential and clinical application prospects of SNORD105 as a drug target can be discovered. In the future, with the continuous development of drug technology, SNORD105 is expected to provide new methods and ideas for the treatment of various diseases.

Protein Name: Small Nucleolar RNA, C/D Box 105

The "SNORD105 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD105 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets